Target
RAC-alpha serine/threonine-protein kinase
Ligand
BDBM50034417
Substrate
n/a
Meas. Tech.
ChEMBL_606815 (CHEMBL1068579)
IC50
20000±n/a nM
Citation
 Du-Cuny, LSong, ZMoses, SPowis, GMash, EAMeuillet, EJZhang, S Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain. Bioorg Med Chem 17:6983-92 (2009) [PubMed]  Article 
Target
Name:
RAC-alpha serine/threonine-protein kinase
Synonyms:
AKT phosphorylation (p-AKT) | AKT1 | AKT1/PPP1CA | AKT1_HUMAN | C-AKT | PKB | PKB alpha | Protein kinase Akt-1 | Protein kinase B | Protein kinase B (AKT1) | Protein kinase B (Akt 1) | Protein kinase B (Akt) | Protein kinase B alpha | Protein kinase B alpha (AKT1) | Proto-oncogene Akt (Akt1) | Proto-oncogene c-Akt (AKT) | Proto-oncogene c-Akt (AKT1) | RAC | RAC-PK-alpha | RAC-alpha serine/threonine-protein kinase (AKT) | RAC-alpha serine/threonine-protein kinase (AKT1) | RAC-alpha serine/threonine-protein kinase (pAKT)
Type:
Enzyme
Mol. Mass.:
55681.25
Organism:
Homo sapiens (Human)
Description:
P31749
Residue:
480
Sequence:
MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA
  
Inhibitor
Name:
BDBM50034417
Synonyms:
4-Amino-N-[1,3,4]thiadiazol-2-yl-benzenesulfonamide | 4-amino-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide | CHEMBL286737 | US9320734, 100
Type:
Small organic molecule
Emp. Form.:
C8H8N4O2S2
Mol. Mass.:
256.305
SMILES:
Nc1ccc(cc1)S(=O)(=O)Nc1nncs1
Structure:
Search PDB for entries with ligand similarity: